Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

A woman with lupus had rare severe symptoms but improved with treatment.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

New treatments for lupus show promise, but more research is needed, especially for children.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

Low free thyroxine (FT4) is common in young lupus patients and needs quick diagnosis and treatment.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.